Range
3.33 - 3.53
Vol / Avg.
145.8K/157.4K
Div / Yield
-
52 Wk
1.84 - 8.16
Mkt Cap
130.5M
Payout Ratio
-
Open
3.44
P/E
-
EPS
-0.37
Shares
39.2M
Outstanding
39.2M
Total Float
29.1M
Benzinga - May 18, 2021, 10:03AM
Benzinga - May 3, 2021, 10:24AM
Benzinga - Apr 15, 2021, 8:39AM
Benzinga - Apr 14, 2021, 8:33AM
Benzinga - Mar 8, 2021, 8:36AM
Benzinga - Mar 8, 2021, 8:29AM
Benzinga - Mar 1, 2021, 9:07AM
Benzinga - Feb 23, 2021, 9:07AM
Benzinga - Jan 27, 2021, 9:01AM
Benzinga - Jan 21, 2021, 3:40PM
Benzinga - Jan 21, 2021, 8:34AM
Benzinga - Jan 21, 2021, 7:38AM
Benzinga - Jan 20, 2021, 4:58PM
Benzinga - Jan 20, 2021, 4:35PM
Benzinga - Jan 19, 2021, 8:35AM
Benzinga - Jan 8, 2021, 9:00AM
Benzinga - Dec 10, 2020, 9:05AM
load more
Sector: Health Care.Industry: Biotechnology
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ONCSOncoSec Medical-4.31%130.5M

OncoSec Medical Frequently Asked Questions

Q

How do I buy OncoSec Medical (ONCS) stock?

A

You can purchase shares of OncoSec Medical (NASDAQ: ONCS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are OncoSec Medical's (ONCS) competitors?

A

Other companies in OncoSec Medical’s space includes: Larimar Therapeutics (NASDAQ:LRMR), Calithera Biosciences (NASDAQ:CALA), NuCana (NASDAQ:NCNA), Genprex (NASDAQ:GNPX) and GlycoMimetics (NASDAQ:GLYC).

Q

What is the target price for OncoSec Medical (ONCS) stock?

A

The latest price target for OncoSec Medical (NASDAQ: ONCS) was reported by BTIG on March 8, 2021. The analyst firm set a price target for 10.00 expecting ONCS to rise to within 12 months (a possible 200.30% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for OncoSec Medical (ONCS)?

A

The stock price for OncoSec Medical (NASDAQ: ONCS) is $3.33 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does OncoSec Medical (ONCS) pay a dividend?

A

There are no upcoming dividends for OncoSec Medical.

Q

When is OncoSec Medical (NASDAQ:ONCS) reporting earnings?

A

OncoSec Medical does not have any upcoming earnings scheduled.

Q

Is OncoSec Medical (ONCS) going to split?

A

There is no upcoming split for OncoSec Medical.

Q

What sector and industry does OncoSec Medical (ONCS) operate in?

A

OncoSec Medical is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.